Streetbeat News

Stock Prices

NGVC

Natural Grocers by Vitamin Cottage (NGVC) shares are trading higher following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:55 pm

CNTA

Centessa Pharmaceuticals' shares surged following the presentation of positive 52-week continuous treatment data from the third year of the ongoing Phase 2a study of SerpinPC for hemophilia treatment.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:50 pm

UI

Ubiquiti shares are trading lower following the announcement of worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:50 pm

BMY

Bristol-Myers Squibb (NYSE:BMY) has seen significant options trading activity, with a bullish sentiment from big-money traders. The trading volume and open interest suggest a focus on a price band between $45.0 and $60.0. Recent trades include both puts and calls, with a notable split in sentiment. Analysts have set an average target price of $52.5, with mixed ratings from Wells Fargo and Redburn Atlantic. The company's stock is currently neutral with a slight increase in price.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 7:45 pm

OWL

Blue Owl Capital's shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:45 pm

GBTC

Bitcoin and Ethereum have seen significant gains, with Bitcoin surging almost 6% and both cryptos up 14% and 11% respectively since Feb. 5. Dogecoin, however, has shown weakness, stalling above the 8-cent mark. The Grayscale Bitcoin Trust ETF (GBTC) has risen about 14% over the last four trading days, potentially setting up for a gap open on Monday. Bitcoin and Ethereum are facing technical resistance levels, while Dogecoin struggles with low trading volume and a lack of direction.

Portfolio Pulse from Melanie Schaffer

February 09, 2024 | 7:43 pm

VCTR

Victory Capital Holdings' shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:40 pm

OSCR

Oscar Health's stock price increased following Goldman Sachs' decision to maintain a Neutral rating on the stock while raising its price target from $8 to $16.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:39 pm

SYBX

Synlogic Inc (NASDAQ:SYBX) stock plummeted by 48.4% to $1.78 after announcing the discontinuation of Synpheny-3, ceasing operations, and a workforce reduction of over 90%. The decision was based on an internal review suggesting the trial wouldn't meet its primary endpoint, not safety concerns. The company is exploring strategic options to enhance shareholder value, including potential acquisitions, mergers, or other transactions. Dr. Aoife Brennan, President and CEO, will leave, retaining only essential personnel for strategic review.

Portfolio Pulse from Henry Khederian

February 09, 2024 | 7:39 pm

DOOR

EMKR

INBS

NET

NWL

PLCE

SYBX

U.S. stocks showed mixed performance with the Nasdaq Composite rising by 1.26% and the S&P 500 gaining 0.55%, while the Dow slightly declined. Newell Brands Inc. reported higher than expected Q4 sales but forecasted a significant sales decline for FY24, impacting its stock. In other news, Intelligent Bio Solutions, Masonite International, and Cloudflare saw significant stock price increases following positive financial results and acquisition news. Conversely, The Children's Place, Synlogic, and EMCORE Corporation experienced substantial drops in their stock prices due to disappointing financial updates and operational changes.

Portfolio Pulse from Avi Kapoor

February 09, 2024 | 7:38 pm